Fletcher Spaght Ventures

FSV Overview

Investment Strategy

Our Team

Advisory Board

Industry Experience

Portfolio Companies


Portfolio Companies

BIOCIUS Life Sciences, Inc.

BIOCIUS Life Sciences, Inc.

Woburn, MA

BIOCIUS Life Sciences develops and markets innovative technologies for drug discovery, with applications for high-throughput screening and in vitro absorption, distribution, metabolism, excretion, and toxicology (ADME-Tox) assays. BIOCIUS' RapidFire mass spec front-end employs nano-scale fluidics to increase throughput from as much as 10x over other sample preparation technologies, accelerating customers' research, development and commercialization projects.

Acquired by Agilent Technologies

Copyright © 2015 Fletcher Spaght Ventures, LP
All Rights Reserved.
222 Berkeley Street • 20th Floor • Boston, MA 02116
617-247-6700 Telephone • 617-247-7757 Facsimile